Circadian Changes of Valproate Kinetics Depending on Meal Condition in Humans

Shigehiro Ohdo, Shigeyuki Nakano, Nobuya Ogawa

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The objective of this study was to examine the effect of meal condition on circadian changes in valproic acid (VPA) kinetics. Two experiments were performed in 16 healthy men that were synchronized with diurnal activity and nocturnal rest as their routine life. In both experiments, four 200‐mg tablets of VPA were given orally on two occasions in the morning (8:30 am) or in the evening (8:30 pm). In each study, a randomized, single‐dose, two‐way crossover design was used, and 2 weeks elapsed between morning and evening trials. In experiment 1, eight subjects took a light meal as breakfast between 8:00 and 8:15 am and a heavy meal as dinner between 6:00 and 6:30 pm to fit the subject's usual food amount. The mean peak plasma concentration (Cmax) was significantly higher (P < .01), the time to peak concentration (tmax) was shorter (P < .05), and the absorption rate (Ka) was larger (P < .05) after the morning dose than after the evening dose. In experiment 2, the size and contents of meal in breakfast and dinner were prepared in the same manner as the standard breakfast for the subjects. Namely, eight subjects took the same light meal between 8:00 and 8:15 am in the morning and between 8:00 and 8:15 pm in the evening. There was no significant circadian change in VPA kinetics under this same meal condition. These results suggest that the differences of meal condition between morning and evening in our daily life play a major role in the mechanism underlying the circadian changes of VPA absorption in man. 1992 American College of Clinical Pharmacology

Original languageEnglish
Pages (from-to)822-826
Number of pages5
JournalThe Journal of Clinical Pharmacology
Volume32
Issue number9
DOIs
Publication statusPublished - Jan 1 1992
Externally publishedYes

Fingerprint

Valproic Acid
Meals
Breakfast
Light
Clinical Pharmacology
Cross-Over Studies
Tablets
Food

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Circadian Changes of Valproate Kinetics Depending on Meal Condition in Humans. / Ohdo, Shigehiro; Nakano, Shigeyuki; Ogawa, Nobuya.

In: The Journal of Clinical Pharmacology, Vol. 32, No. 9, 01.01.1992, p. 822-826.

Research output: Contribution to journalArticle

@article{7199624b07904dae874c3e6cbaa9ca98,
title = "Circadian Changes of Valproate Kinetics Depending on Meal Condition in Humans",
abstract = "The objective of this study was to examine the effect of meal condition on circadian changes in valproic acid (VPA) kinetics. Two experiments were performed in 16 healthy men that were synchronized with diurnal activity and nocturnal rest as their routine life. In both experiments, four 200‐mg tablets of VPA were given orally on two occasions in the morning (8:30 am) or in the evening (8:30 pm). In each study, a randomized, single‐dose, two‐way crossover design was used, and 2 weeks elapsed between morning and evening trials. In experiment 1, eight subjects took a light meal as breakfast between 8:00 and 8:15 am and a heavy meal as dinner between 6:00 and 6:30 pm to fit the subject's usual food amount. The mean peak plasma concentration (Cmax) was significantly higher (P < .01), the time to peak concentration (tmax) was shorter (P < .05), and the absorption rate (Ka) was larger (P < .05) after the morning dose than after the evening dose. In experiment 2, the size and contents of meal in breakfast and dinner were prepared in the same manner as the standard breakfast for the subjects. Namely, eight subjects took the same light meal between 8:00 and 8:15 am in the morning and between 8:00 and 8:15 pm in the evening. There was no significant circadian change in VPA kinetics under this same meal condition. These results suggest that the differences of meal condition between morning and evening in our daily life play a major role in the mechanism underlying the circadian changes of VPA absorption in man. 1992 American College of Clinical Pharmacology",
author = "Shigehiro Ohdo and Shigeyuki Nakano and Nobuya Ogawa",
year = "1992",
month = "1",
day = "1",
doi = "10.1002/j.1552-4604.1992.tb03889.x",
language = "English",
volume = "32",
pages = "822--826",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "9",

}

TY - JOUR

T1 - Circadian Changes of Valproate Kinetics Depending on Meal Condition in Humans

AU - Ohdo, Shigehiro

AU - Nakano, Shigeyuki

AU - Ogawa, Nobuya

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The objective of this study was to examine the effect of meal condition on circadian changes in valproic acid (VPA) kinetics. Two experiments were performed in 16 healthy men that were synchronized with diurnal activity and nocturnal rest as their routine life. In both experiments, four 200‐mg tablets of VPA were given orally on two occasions in the morning (8:30 am) or in the evening (8:30 pm). In each study, a randomized, single‐dose, two‐way crossover design was used, and 2 weeks elapsed between morning and evening trials. In experiment 1, eight subjects took a light meal as breakfast between 8:00 and 8:15 am and a heavy meal as dinner between 6:00 and 6:30 pm to fit the subject's usual food amount. The mean peak plasma concentration (Cmax) was significantly higher (P < .01), the time to peak concentration (tmax) was shorter (P < .05), and the absorption rate (Ka) was larger (P < .05) after the morning dose than after the evening dose. In experiment 2, the size and contents of meal in breakfast and dinner were prepared in the same manner as the standard breakfast for the subjects. Namely, eight subjects took the same light meal between 8:00 and 8:15 am in the morning and between 8:00 and 8:15 pm in the evening. There was no significant circadian change in VPA kinetics under this same meal condition. These results suggest that the differences of meal condition between morning and evening in our daily life play a major role in the mechanism underlying the circadian changes of VPA absorption in man. 1992 American College of Clinical Pharmacology

AB - The objective of this study was to examine the effect of meal condition on circadian changes in valproic acid (VPA) kinetics. Two experiments were performed in 16 healthy men that were synchronized with diurnal activity and nocturnal rest as their routine life. In both experiments, four 200‐mg tablets of VPA were given orally on two occasions in the morning (8:30 am) or in the evening (8:30 pm). In each study, a randomized, single‐dose, two‐way crossover design was used, and 2 weeks elapsed between morning and evening trials. In experiment 1, eight subjects took a light meal as breakfast between 8:00 and 8:15 am and a heavy meal as dinner between 6:00 and 6:30 pm to fit the subject's usual food amount. The mean peak plasma concentration (Cmax) was significantly higher (P < .01), the time to peak concentration (tmax) was shorter (P < .05), and the absorption rate (Ka) was larger (P < .05) after the morning dose than after the evening dose. In experiment 2, the size and contents of meal in breakfast and dinner were prepared in the same manner as the standard breakfast for the subjects. Namely, eight subjects took the same light meal between 8:00 and 8:15 am in the morning and between 8:00 and 8:15 pm in the evening. There was no significant circadian change in VPA kinetics under this same meal condition. These results suggest that the differences of meal condition between morning and evening in our daily life play a major role in the mechanism underlying the circadian changes of VPA absorption in man. 1992 American College of Clinical Pharmacology

UR - http://www.scopus.com/inward/record.url?scp=0026709313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026709313&partnerID=8YFLogxK

U2 - 10.1002/j.1552-4604.1992.tb03889.x

DO - 10.1002/j.1552-4604.1992.tb03889.x

M3 - Article

C2 - 1430301

AN - SCOPUS:0026709313

VL - 32

SP - 822

EP - 826

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 9

ER -